US Stock MarketDetailed Quotes

UNCY Unicycive Therapeutics

Watchlist
  • 0.5420
  • -0.0280-4.91%
Close Feb 25 16:00 ET
58.76MMarket Cap-1.18P/E (TTM)

About Unicycive Therapeutics Company

Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.

Company Profile

SymbolUNCY
Company NameUnicycive Therapeutics
Listing DateJul 13, 2021
Issue Price5.00
Founded2016
CEODr. Shalabh Gupta, M.D.
MarketNASDAQ
Employees14
Fiscal Year Ends12-31
Address4300 El Camino Real,Suite 210
CityLos Altos
ProvinceCalifornia
CountryUnited States of America
Zip Code94022
Phone1-650-351-4495

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Shalabh Gupta, M.D.
  • Chief Executive Officer, President and Chairman of the Board
  • 4.07M
  • John W. Townsend
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Douglas Jermasek
  • Executive Vice President, Corporate Strategy
  • 1.27M
  • Dr. Pramod Gupta, M.D.
  • Executive Vice President, Pharmaceutical and Business Operations
  • 1.53M
  • Dr. Sandeep Laumas, M.D.
  • Independent Director
  • 181.02K
  • Dr. Saraswati Kenkare-Mitra, PhD
  • Independent Director
  • 135.58K
  • Dr. John Ryan, M.D.,PhD
  • Independent Director
  • 147.22K
  • Dr. Gaurav Aggarwal, M.D.
  • Independent Director
  • 138.58K

Trending Stocks

Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More